ストックスクリーナーアプリを入手
149.26
2.78%
4.04
前日終値:
$145.22
開ける：
$145.12
24時間の取引高:
332.69K
Relative Volume:
0.64
時価総額：
$7.52B
収益：
$338.46M
当期純損益:
$-310.96M
株価収益率:
-22.86
EPS:
-6.53
ネットキャッシュフロー:
$-132.82M
1週間 パフォーマンス:
+0.98%
1か月 パフォーマンス:
+8.32%
6か月 パフォーマンス:
+35.80%
1年 パフォーマンス:
+51.05%
1日の値動き範囲:
$144.97
$149.87
1週間の範囲:
$144.00
$151.63
52週間の値動き範囲:
$75.56
$152.94
Axsome Therapeutics Inc Stock (AXSM) Company Profile
名前
Axsome Therapeutics Inc
セクター
電話
(212) 332-3241
住所
ONE WORLD TRADE CENTER, 29TH FLOOR, NEW YORK
AXSM を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
AXSM
Axsome Therapeutics Inc
|
149.26 | 7.32B | 338.46M | -310.96M | -132.82M | -6.53 |
|
VRTX
Vertex Pharmaceuticals Inc
|
444.64 | 110.88B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
726.21 | 72.79B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
890.11 | 54.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
404.46 | 54.85B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
189.85 | 41.41B | 447.02M | -1.18B | -906.14M | -6.1812 |
Axsome Therapeutics Inc Stock (AXSM) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-10-01 | 開始されました | B. Riley Securities | Buy |
| 2025-09-03 | 再開されました | Wells Fargo | Overweight |
| 2025-07-03 | 再開されました | Morgan Stanley | Overweight |
| 2025-06-03 | 開始されました | Oppenheimer | Outperform |
| 2025-04-07 | 開始されました | Jefferies | Buy |
| 2025-02-11 | 開始されました | Deutsche Bank | Buy |
| 2024-12-31 | 繰り返されました | Mizuho | Outperform |
| 2024-09-03 | 開始されました | Wells Fargo | Overweight |
| 2024-08-06 | アップグレード | BofA Securities | Neutral → Buy |
| 2024-07-22 | 開始されました | Needham | Buy |
| 2024-04-29 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2024-03-19 | 開始されました | Robert W. Baird | Outperform |
| 2024-02-06 | 開始されました | UBS | Buy |
| 2024-01-25 | 開始されました | RBC Capital Mkts | Outperform |
| 2023-12-13 | 開始されました | Citigroup | Buy |
| 2023-08-08 | アップグレード | BofA Securities | Underperform → Neutral |
| 2023-01-05 | 開始されました | Piper Sandler | Neutral |
| 2022-11-01 | 開始されました | Loop Capital | Buy |
| 2022-09-07 | 再開されました | Mizuho | Buy |
| 2021-08-10 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2021-06-10 | 開始されました | Berenberg | Buy |
| 2021-01-08 | 開始されました | Jefferies | Buy |
| 2020-12-16 | 開始されました | Mizuho | Buy |
| 2020-09-29 | 開始されました | BofA Securities | Underperform |
| 2020-09-10 | 開始されました | Morgan Stanley | Overweight |
| 2020-04-28 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-04-14 | 開始されました | Cowen | Outperform |
| 2019-12-30 | 繰り返されました | H.C. Wainwright | Buy |
| 2019-12-17 | 繰り返されました | H.C. Wainwright | Buy |
| 2019-12-16 | 繰り返されました | Guggenheim | Buy |
| 2019-10-16 | 開始されました | Guggenheim | Buy |
| 2019-09-18 | 開始されました | William Blair | Outperform |
| 2019-05-28 | 開始されました | SunTrust | Buy |
| 2019-05-23 | 繰り返されました | H.C. Wainwright | Buy |
| 2019-04-08 | 開始されました | SVB Leerink | Outperform |
| 2019-03-15 | 繰り返されました | H.C. Wainwright | Buy |
| 2016-10-03 | 再開されました | Brean Capital | Buy |
| 2015-12-15 | 開始されました | Cantor Fitzgerald | Buy |
| 2015-12-14 | 開始されました | Ladenburg Thalmann | Buy |
すべてを表示
Axsome Therapeutics Inc (AXSM) 最新ニュース
Hood River Capital Management LLC Acquires Shares of 371,104 Axsome Therapeutics, Inc. $AXSM - MarketBeat
Jump Financial LLC Purchases 35,860 Shares of Axsome Therapeutics, Inc. $AXSM - MarketBeat
Price-Driven Insight from (AXSM) for Rule-Based Strategy - news.stocktradersdaily.com
Kennedy Capital Management LLC Boosts Holdings in Axsome Therapeutics, Inc. $AXSM - MarketBeat
Quantbot Technologies LP Grows Position in Axsome Therapeutics, Inc. $AXSM - MarketBeat
Norges Bank Acquires New Holdings in Axsome Therapeutics, Inc. $AXSM - MarketBeat
Schroder Investment Management Group Has $3.91 Million Holdings in Axsome Therapeutics, Inc. $AXSM - MarketBeat
Affinity Asset Advisors LLC Has $5.22 Million Holdings in Axsome Therapeutics, Inc. $AXSM - MarketBeat
Axsome Therapeutics, Inc. (NASDAQ:AXSM) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
Insider Selling: Axsome Therapeutics (NASDAQ:AXSM) CEO Sells 10,558 Shares of Stock - MarketBeat
Axsome Therapeutics (NASDAQ:AXSM) CEO Sells $7,121,346.68 in Stock - MarketBeat
Axsome Therapeutics (NASDAQ:AXSM) CEO Herriot Tabuteau Sells 20,163 Shares - MarketBeat
Can Axsome Therapeutics Inc. (19X) stock sustain breakout momentum2025 Performance Recap & Fast Entry High Yield Tips - Newser
Will Axsome Therapeutics Inc. stock outperform international peersCEO Change & Smart Money Movement Alerts - Newser
Is Axsome Therapeutics Inc. stock recession proof2025 AllTime Highs & Reliable Trade Execution Plans - Newser
Axsome therapeutics CEO Tabuteau sells $11.6 million in shares By Investing.com - Investing.com South Africa
Axsome therapeutics CEO Tabuteau sells $11.6 million in shares - Investing.com
Will Axsome Therapeutics Inc. (19X) stock outperform small cap peersEarnings Recap Summary & Growth Focused Investment Plans - Newser
Will Axsome Therapeutics Inc. stock outperform value stocksBull Run & Risk Controlled Swing Trade Alerts - Newser
Hsbc Holdings PLC Has $10.24 Million Stock Position in Axsome Therapeutics, Inc. $AXSM - MarketBeat
Is Axsome Therapeutics Inc. (19X) stock trading at attractive multiplesWeekly Trade Report & High Yield Equity Trading Tips - Newser
Rhumbline Advisers Has $6.45 Million Position in Axsome Therapeutics, Inc. $AXSM - MarketBeat
What momentum indicators show for Axsome Therapeutics Inc. stockJuly 2025 Action & Risk Managed Trade Strategies - Newser
Is Axsome Therapeutics Inc. (19X) stock included in top ETFsTrade Exit Report & Low Drawdown Trading Strategies - Newser
Axsome (AXSM) Up 5.3% Since Last Earnings Report: Can It Continue? - Yahoo Finance
Granite Investment Partners LLC Has $13.42 Million Stock Position in Axsome Therapeutics, Inc. $AXSM - MarketBeat
How Axsome Therapeutics Inc. (19X) stock trades pre earningsJuly 2025 News Drivers & Weekly Chart Analysis and Trade Guides - Newser
Axsome Therapeutics, Inc. $AXSM Shares Purchased by Swiss National Bank - MarketBeat
2 Under-the-Radar Stocks to Buy Heading Into 2026 - sharewise.com
Axsome Therapeutics (AXSM): Evaluating Valuation Following Recent Share Price Momentum and Pipeline Expansion - Yahoo Finance
2 Under-the-Radar Stocks to Buy Heading Into 2026 - The Motley Fool
Axsome Therapeutics, Inc. $AXSM Shares Sold by Loomis Sayles & Co. L P - MarketBeat
Quadrature Capital Ltd Boosts Holdings in Axsome Therapeutics, Inc. $AXSM - MarketBeat
2,366 Shares in Axsome Therapeutics, Inc. $AXSM Bought by Elevation Point Wealth Partners LLC - MarketBeat
Capital Fund Management S.A. Buys 47,738 Shares of Axsome Therapeutics, Inc. $AXSM - MarketBeat
Jefferies Financial Group Inc. Makes New $261,000 Investment in Axsome Therapeutics, Inc. $AXSM - MarketBeat
F m Investments LLC Takes $3.36 Million Position in Axsome Therapeutics, Inc. $AXSM - MarketBeat
Axsome Therapeutics, Inc. $AXSM Shares Sold by PNC Financial Services Group Inc. - MarketBeat
Is Axsome Therapeutics Inc a good long term investmentHigh Dividend Yield Stocks & Free Turn Volatility To Profit - earlytimes.in
Axsome Therapeutics Stock (AXSM) Opinions on Recent Revenue Surge - Quiver Quantitative
Franklin Resources Inc. Acquires 51,995 Shares of Axsome Therapeutics, Inc. $AXSM - MarketBeat
Atika Capital Management LLC Has $4.82 Million Holdings in Axsome Therapeutics, Inc. $AXSM - MarketBeat
Axsome (AXSM) Q3 2025 Earnings Call Transcript - The Globe and Mail
Axsome Therapeutics, Inc. $AXSM Shares Sold by Rhenman & Partners Asset Management AB - MarketBeat
Zacks Research Analysts Lower Earnings Estimates for AXSM - MarketBeat
Axsome Therapeutics, Inc. $AXSM Shares Purchased by Ensign Peak Advisors Inc - MarketBeat
Why Axsome Therapeutics Inc. stock is rated strong buyProfit Target & High Conviction Investment Ideas - BỘ NỘI VỤ
(AXSM) Price Dynamics and Execution-Aware Positioning - news.stocktradersdaily.com
Axsome Therapeutics Inc. (AXSM) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Axsome Therapeutics, Inc. $AXSM Shares Purchased by SG Americas Securities LLC - MarketBeat
Axsome’s AXS-14 Gets Regulatory Setback with RTF, says Morgan Stanley - MSN
Axsome Therapeutics Inc (AXSM) 財務データ
収益
当期純利益
現金流量
EPS
0.45%
0.12%
大文字化:
|
ボリューム (24 時間):